Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 12 de 12
Filter
Add more filters










Publication year range
1.
Contact Dermatitis ; 84(6): 431-438, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33350482

ABSTRACT

BACKGROUND: Allergic contact dermatitis (ACD) from topical medication often occurs in occluded areas, for example, with wound treatment, but also in certain body locations, such as the anogenital area. OBJECTIVES: To investigate the demographics and specific lesion location of patients with ACD from topical drugs applied onto the (peri)anal/genital area, and to identify the respective causal topical pharmaceutical products and ingredients involved. METHODS: From January 2000 to December 10, 2018, 532 patients were tested with the baseline series, sometimes with additional series, and the topical medication used along with the ingredients. The relevant data were extracted from our electronic databases developed in-house. RESULTS: Forty-four patients (9%) out of 473 patients suffering from lesions in the (peri)anal/genital area had positive patch test results to topical drug preparations and/or their ingredients, sometimes in association with cosmetics for intimate hygiene. The most frequent sensitizing active principles were local anaesthetics and corticosteroids, while wool alcohols and to a minor extent benzoic acid were the most frequent culprits among the vehicle components and preservative agents, respectively. CONCLUSIONS: The local conditions (eg, occlusion, sweating, moist) in the anogenital area may favour skin sensitization to topical medication used to treat various skin diseases.


Subject(s)
Adrenal Cortex Hormones/adverse effects , Anesthetics, Local/adverse effects , Anus Diseases/chemically induced , Cosmetics/adverse effects , Dermatitis, Allergic Contact/etiology , Genital Diseases, Female/chemically induced , Genital Diseases, Male/chemically induced , Adolescent , Adult , Aged , Benzoic Acid/adverse effects , Child , Child, Preschool , Female , Humans , Hygiene , Infant , Lanolin/adverse effects , Male , Middle Aged , Preservatives, Pharmaceutical/adverse effects , Retrospective Studies , Young Adult
4.
Expert Opin Drug Metab Toxicol ; 12(10): 1169-79, 2016 Oct.
Article in English | MEDLINE | ID: mdl-27351777

ABSTRACT

INTRODUCTION: Activation of fatty acids by the acyl-CoA synthetases (ACSs) is the vital first step in fatty acid metabolism. The enzymatic and physiological characterization of the human xenobiotic/medium chain fatty acid: CoA ligases (ACSMs) has been severely neglected even though xenobiotics, such as benzoate and salicylate, are detoxified through this pathway. AREAS COVERED: This review will focus on the nomenclature and substrate specificity of the human ACSM ligases; the biochemical and enzymatic characterization of ACSM1 and ACSM2B; the high sequence homology of the ACSM2 genes (ACSM2A and ACSM2B) as well as what is currently known regarding disease association studies. EXPERT OPINION: Several discrepancies exist in the current literature that should be taken note of. For example, the single nucleotide polymorphisms (SNPs) reported to be associated with aspirin metabolism and multiple risk factors of metabolic syndrome are incorrect. Kinetic data on the substrate specificity of the human ACSM ligases are non-existent and currently no data exist on the influence of SNPs on the enzyme activity of these ligases. One of the biggest obstacles currently in the field is that glycine conjugation is continuously studied as a one-step process, which means that key regulatory factors of the two individual steps remain unknown.


Subject(s)
Aspirin/metabolism , Benzoic Acid/metabolism , Coenzyme A Ligases/metabolism , Animals , Aspirin/adverse effects , Benzoic Acid/adverse effects , Coenzyme A Ligases/genetics , Fatty Acids/metabolism , Humans , Polymorphism, Single Nucleotide , Substrate Specificity , Xenobiotics/adverse effects , Xenobiotics/metabolism
5.
Article in English | MEDLINE | ID: mdl-22264192

ABSTRACT

An exposure assessment was performed to estimate the potential intake of preservatives in the Austrian population. Food consumption data of different population groups, such as preschool children aged 3-6 years, female and male adults aged 19-65 years were used for calculation. Levels of the preservatives in food were derived from analyses conducted from January 2007 to August 2010. Dietary intakes of the preservatives were estimated and compared to the respective acceptable daily intakes (ADIs). In the average-intake scenario, assuming that consumers randomly consume food products that do or do not contain food additives, estimated dietary intakes of all studied preservatives are well below the ADI for all population groups. Sulphite exposure accounted for 34%, 84% and 89% of the ADI in preschool children, females and males, respectively. The mean estimated daily intake of benzoic acid was 32% (preschool children), 31% (males) and 36% (females) of the ADI. Sorbic acid intakes correspond to 7% of the ADI in preschool children and 6% of the ADI in adults. In the high-intake scenario assuming that consumers always consume food products that contain additives and considering a kind of brand loyalty of consumers, the ADI is exceeded for sulphites among adults (119 and 124%, respectively). Major contributors to the total intake of sulphites were wine and dried fruits for adults. Mean estimated dietary intakes of benzoic acid exceeded the ADI in all population groups, 135% in preschool children, 124% in females and 118% of the ADI in males, respectively. Dietary intakes of sorbic acid are well below the ADI, accounting for a maximum of 30% of the ADI in preschool children. The highest contributors to benzoic and sorbic acid exposure were fish and fish products mainly caused by high consumption data of this large food group, including also mayonnaise-containing fish salads. Other important sources of sorbic acid were bread, buns and toast bread and fruit and vegetable juices.


Subject(s)
Benzoic Acid/administration & dosage , Diet , Food Preservatives/administration & dosage , Sorbic Acid/administration & dosage , Sulfites/administration & dosage , Adult , Age Factors , Aged , Austria , Benzoic Acid/adverse effects , Child , Child, Preschool , Diet/adverse effects , Female , Food Preservatives/adverse effects , Food, Preserved/adverse effects , Food, Preserved/analysis , Humans , Male , Middle Aged , Nutrition Surveys , Risk Assessment , Sorbic Acid/adverse effects , Sulfites/adverse effects , Young Adult
8.
Allergy ; 57(12): 1195-9, 2002 Dec.
Article in English | MEDLINE | ID: mdl-12464050

ABSTRACT

BACKGROUND: A new technique, cutaneous field stimulation (CFS), which activates electrically unmyelinated C-fibers, is used to treat localized itch. Its action is similar to that of capsaicin, the pungent agent in hot peppers, which enhances delayed allergic reactions. The aim of the study was to investigate how experimental contact dermatitis responds to CFS. METHODS: Twelve patients with contact dermatitis in response to nickel were treated by CFS for 1 h each for four consecutive days. A flexible plate containing electrodes was applied to a test area on the upper arm and was stimulated by a constant current (0.8 mA). On the fifth day, patients were provoked by epicutaneous application of nickel sulfate (allergic contact dermatitis) and benzalkonium chloride (irritant contact dermatitis), and by intradermal tuberculin (delayed immunologic reaction). Twelve other patients with IgE-mediated allergy were treated by CFS on the lower arm for 1 h and were then pricked with histamine and allergen extracts (wheal volume was measured) and were tested using benzoic acid (nonimmunologic contact urticaria; closed test). Ten of these patients were also treated by CFS for four days, and experiments were performed on the fifth day. RESULTS: Test reactions to nickel, benzalkonium, and tuberculin were found to be unaffected by CFS treatment. Although allergic prick test reactions were enhanced (by 28%) after a single CFS treatment, the associated itch was significantly reduced both after single and repeated CFS treatments (by 65% and 38%, respectively). CONCLUSIONS: Repeated use of CFS to reduce itch has no adverse effects on contact dermatitis.


Subject(s)
Dermatitis, Allergic Contact/physiopathology , Dermatitis, Allergic Contact/therapy , Electric Stimulation Therapy , Nerve Fibers/physiology , Pruritus/physiopathology , Pruritus/therapy , Sensory Receptor Cells/physiology , Administration, Cutaneous , Adult , Aged , Anti-Infective Agents, Local/adverse effects , Anti-Infective Agents, Local/therapeutic use , Antifungal Agents/adverse effects , Antifungal Agents/therapeutic use , Benzalkonium Compounds/adverse effects , Benzalkonium Compounds/therapeutic use , Benzoic Acid/adverse effects , Benzoic Acid/therapeutic use , Cross Reactions/drug effects , Dermatitis, Irritant/etiology , Drug Eruptions/etiology , Female , Humans , Hypersensitivity, Immediate/physiopathology , Hypersensitivity, Immediate/therapy , Male , Middle Aged , Nickel/adverse effects , Nickel/therapeutic use , Radiopharmaceuticals/adverse effects , Radiopharmaceuticals/therapeutic use , Skin Tests , Treatment Outcome , Tuberculin/drug effects , Urticaria/chemically induced
9.
Ecotoxicol Environ Saf ; 53(1): 65-9, 2002 Sep.
Article in English | MEDLINE | ID: mdl-12481859

ABSTRACT

With the application of a genetically modified yeast, estrogen receptor-activating compounds were detected in the soot and emission gas of a wood-burning household stove. The EC50 value of 17beta-estradiol was divided by the EC50 value of soot, and the obtained relative estrogenic value for raw soot was 2.37E-5, indicating that soot was about 100,000 times less estrogenic than 17beta-estradiol. Chemical analysis revealed that alkyl phenol, benzonic acid, and PAHs represented the major constituents in the most potent fractions of the soot. Along with PAHs, other constituents might also contribute to the estrogenicity of soot.


Subject(s)
Benzoic Acid/adverse effects , Carbon/adverse effects , Carbon/chemistry , Phenols/adverse effects , Polycyclic Aromatic Hydrocarbons/adverse effects , Biological Assay , Estradiol/pharmacology , Receptors, Estrogen/drug effects , Reference Values , Yeasts
10.
Int J Toxicol ; 20 Suppl 3: 23-50, 2001.
Article in English | MEDLINE | ID: mdl-11766131

ABSTRACT

Benzyl Alcohol is an aromatic alcohol used in a wide variety of cosmetic formulations as a fragrance component, preservative, solvent, and viscosity-decreasing agent. Benzoic Acid is an aromatic acid used in a wide variety of cosmetics as a pH adjuster and preservative. Sodium Benzoate is the sodium salt of Benzoic Acid used as a preservative, also in a wide range of cosmetic product types. Benzyl Alcohol is metabolized to Benzoic Acid, which reacts with glycine and excreted as hippuric acid in the human body. Acceptable daily intakes were established by the World Health Organization at 5 mg/kg for Benzyl Alcohol, Benzoic Acid, and Sodium Benzoate. Benzoic Acid and Sodium Benzoate are generally recognized as safe in foods according to the U.S. Food and Drug Administration. No adverse effects of Benzyl Alcohol were seen in chronic exposure animal studies using rats and mice. Effects of Benzoic Acid and Sodium Benzoate in chronic exposure animal studies were limited to reduced feed intake and reduced growth. Some differences between control and Benzyl Alcohol-treated populations were noted in one reproductive toxicity study using mice, but these were limited to lower maternal body weights and decreased mean litter weights. Another study also noted that fetal weight was decreased compared to controls, but a third study showed no differences between control and Benzyl Alcohol-treated groups. Benzoic Acid was associated with an increased number of resorptions and malformations in hamsters, but there were no reproductive or developmental toxicty findings in studies using mice and rats exposed to Sodium Benzoate, and, likewise, Benzoic Acid was negative in two rat studies. Genotoxicity tests for these ingredients were mostly negative, but there were some assays that were positive. Carcinogenicity studies, however, were negative. Clinical data indicated that these ingredients can produce nonimmunologic contact urticaria and nonimmunologic immediate contact reactions, characterized by the appearance of wheals, erythema, and pruritus. In one study, 5% Benzyl Alcohol elicited a reaction, and in another study, 2% Benzoic Acid did likewise. Benzyl Alcohol, however, was not a sensitizer at 10%, nor was Benzoic Acid a sensitizer at 2%. Recognizing that the nonimmunologic reactions are strictly cutaneous, likely involving a cholinergic mechanism, it was concluded that these ingredients could be used safely at concentrations up to 5%, but that manufacturers should consider the nonimmunologic phenomena when using these ingredients in cosmetic formulations designed for infants and children. Additionally, Benzyl Alcohol was considered safe up to 10% for use in hair dyes. The limited body exposure, the duration of use, and the frequency of use were considered in concluding that the nonimmunologic reactions would not be a concern. Because of the wide variety of product types in which these ingredients may be used, it is likely that inhalation may be a route of exposure. The available safety tests are not considered sufficient to support the safety of these ingredients in formulations where inhalation is a route of exposure. Inhalation toxicity data are needed to complete the safety assessment of these ingredients where inhalation can occur.


Subject(s)
Benzoic Acid/adverse effects , Benzyl Alcohol/adverse effects , Cosmetics/adverse effects , Sodium Benzoate/adverse effects , Animals , Benzoic Acid/chemistry , Benzoic Acid/toxicity , Benzyl Alcohol/chemistry , Benzyl Alcohol/toxicity , Carcinogenicity Tests , Consumer Product Safety/standards , Cosmetics/chemistry , Cosmetics/toxicity , Dermatitis, Phototoxic/etiology , Humans , Inhalation Exposure/adverse effects , Lethal Dose 50 , Muscle, Smooth/drug effects , Mutagenicity Tests , Photosensitivity Disorders/chemically induced , Skin Diseases/chemically induced , Sodium Benzoate/chemistry , Sodium Benzoate/toxicity , Toxicity Tests, Acute , United States , United States Food and Drug Administration/standards , Urticaria/chemically induced
SELECTION OF CITATIONS
SEARCH DETAIL
...